Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021

Rhea-AI Summary

Tandem Diabetes Care (NASDAQ: TNDM) is set to release its second quarter 2021 results on August 4, 2021, after market close. A conference call will follow at 4:30 PM ET to discuss financial and operational outcomes. Investors can join via a toll-free number or webcast. The company focuses on innovative insulin delivery solutions, with its flagship product being the t:slim X2™ insulin pump, which supports remote updates and integrated glucose monitoring.

Positive

• Tandem's flagship product, the t:slim X2™, features innovative technology with remote software updates and integrated continuous glucose monitoring.

Negative

• None.

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2021 results after the financial markets close on Wednesday, August 4, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2021 financial and operating results.

Conference Call/Webcast Details:
Date: August 4, 2021
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 6897987
Webcast Link: https://edge.media-server.com/mmc/p/ttkpgjat

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005658/en/

FAQ

When will Tandem Diabetes Care release its Q2 2021 earnings?

Tandem Diabetes Care will release its second quarter 2021 results after market close on August 4, 2021.

What is the schedule for the Tandem Diabetes Care conference call?

The conference call for Tandem Diabetes Care will be held on August 4, 2021, at 4:30 PM Eastern Time.

How can I access the Tandem Diabetes Care earnings call?

You can access the Tandem Diabetes Care earnings call by calling (855) 427-4396 for toll-free or (484) 756-4261 for international calls, using Conference ID 6897987.

What is the flagship product of Tandem Diabetes Care?

Tandem Diabetes Care's flagship product is the t:slim X2™ insulin pump, known for its advanced technology.